Cargando…
Utility of epirubicin‐incorporating micelles tagged with anti‐tissue factor antibody clone with no anticoagulant effect
Tissue factor (TF), an initiator of the extrinsic blood coagulation cascade, is overexpressed in different types of cancer. Tissue factor overexpression is also known as a poor prognostic factor in pancreatic cancer. We recently developed anti‐TF antibody (clone1849)‐conjugated epirubicin‐incorporat...
Autores principales: | Sugaya, Akinori, Hyodo, Ichinosuke, Koga, Yoshikatsu, Yamamoto, Yoshiyuki, Takashima, Hiroki, Sato, Ryuta, Tsumura, Ryo, Furuya, Fumiaki, Yasunaga, Masahiro, Harada, Mitsunori, Tanaka, Ryosuke, Matsumura, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814265/ https://www.ncbi.nlm.nih.gov/pubmed/26676840 http://dx.doi.org/10.1111/cas.12863 |
Ejemplares similares
-
Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models
por: Yamamoto, Yoshiyuki, et al.
Publicado: (2015) -
Antitumor effect of antitissue factor antibody‐MMAE conjugate in human pancreatic tumor xenografts
por: Koga, Yoshikatsu, et al.
Publicado: (2015) -
Evaluation of the antitumor mechanism of antibody‐drug conjugates against tissue factor in stroma‐rich allograft models
por: Tsumura, Ryo, et al.
Publicado: (2019) -
Preparation and characterization of anti-tissue factor single-chain variable fragment antibody for cancer diagnosis
por: Sato, Ryuta, et al.
Publicado: (2014) -
Optimal Maintenance Strategy for First-Line Oxaliplatin-Containing Therapy with or without Bevacizumab in Patients with Metastatic Colorectal Cancer: A Meta-Analysis
por: Moriwaki, Toshikazu, et al.
Publicado: (2021)